Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    June 2022
  1. CASTILHO JL, Bian A, Jenkins CA, Shepherd BE, et al
    CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    J Natl Cancer Inst. 2022;114:854-862.
    PubMed     Abstract available


  2. MOSS JL, Pinto CN, Srinivasan S, Cronin KA, et al
    Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018.
    J Natl Cancer Inst. 2022;114:829-836.
    PubMed     Abstract available


  3. GOLDBERG RM, Adams R, Buyse M, Eng C, et al
    Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
    J Natl Cancer Inst. 2022;114:819-828.
    PubMed     Abstract available


    May 2022

  4. Correction to: Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
    J Natl Cancer Inst. 2022 May 20. pii: 6590000. doi: 10.1093.
    PubMed    


  5. CASTANON A, Parmar D, Massat N, Sasieni P, et al
    Benefit of biennial faecal occult blood screening on colorectal cancer in England: A population-based case-control study.
    J Natl Cancer Inst. 2022 May 16. pii: 6586300. doi: 10.1093.
    PubMed     Abstract available


  6. TIAN Y, Kim AE, Bien SA, Lin Y, et al
    Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk.
    J Natl Cancer Inst. 2022 May 5. pii: 6581085. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  7. LADABAUM U, Church TR, Feng Z, Ransohoff DF, et al
    Counting Advanced Pre-Cancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity.
    J Natl Cancer Inst. 2022 Feb 4. pii: 6522121. doi: 10.1093.
    PubMed     Abstract available


  8. HEIN DM, Deng W, Bleile M, Kazmi SA, et al
    Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2022 Feb 2. pii: 6520467. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  9. LEE LH, Davis L, Ylagan L, Omilian AR, et al
    Identification of a Subset of Stage I Colorectal Cancer Patients with High Recurrence Risk.
    J Natl Cancer Inst. 2022 Jan 30. pii: 6517508. doi: 10.1093.
    PubMed     Abstract available


  10. MURPHY N, Song M, Papadimitriou N, Carreras-Torres R, et al
    Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis.
    J Natl Cancer Inst. 2022 Jan 20. pii: 6512063. doi: 10.1093.
    PubMed     Abstract available


  11. ARCHAMBAULT AN, Jeon J, Lin Y, Thomas M, et al
    Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study.
    J Natl Cancer Inst. 2022 Jan 13. pii: 6506525. doi: 10.1093.
    PubMed     Abstract available


  12. SHANKARAN V, Unger JM, Darke AK, Suga JM, et al
    S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.
    J Natl Cancer Inst. 2022 Jan 4. pii: 6492636. doi: 10.1093.
    PubMed     Abstract available


  13. GIOVANNUCCI E
    Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Jan 3. pii: 6493343. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  14. WERNLY S, Datz C, Wernly B
    RE: Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Dec 25. pii: 6483088. doi: 10.1093.
    PubMed    


    October 2021
  15. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  16. FORMICA V, Sera F, Cremolini C, Riondino S, et al
    KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2021 Sep 20. pii: 6372696. doi: 10.1093.
    PubMed     Abstract available


  17. YIN J, Salem ME, Dixon JG, Jin Z, et al
    Re-Evaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
    J Natl Cancer Inst. 2021 Sep 10. pii: 6368068. doi: 10.1093.
    PubMed     Abstract available


  18. MORRIS JS
    Disease-Free Survival is a Promising Surrogate for Overall Survival in Colorectal Cancer Studies.
    J Natl Cancer Inst. 2021 Sep 10. pii: 6368067. doi: 10.1093.
    PubMed    


  19. POST CCB, Stelloo E, Smit VTHBM, Ruano D, et al
    Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer.
    J Natl Cancer Inst. 2021;113:1212-1220.
    PubMed     Abstract available


  20. LEE MS, Kopetz S
    Are Homologous Recombination Deficiency Mutations Relevant in Colorectal Cancer?
    J Natl Cancer Inst. 2021 Sep 1. pii: 6361597. doi: 10.1093.
    PubMed    


  21. MORETTO R, Elliott A, Zhang J, Arai H, et al
    Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.
    J Natl Cancer Inst. 2021 Sep 1. pii: 6361603. doi: 10.1093.
    PubMed     Abstract available


  22. LU SSM, Mohammed Z, Haggstrom C, Myte R, et al
    Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study.
    J Natl Cancer Inst. 2021 Sep 1. pii: 6360113. doi: 10.1093.
    PubMed     Abstract available


  23. ZHANG J, Sears CL
    Antibiotic Use Impacts Colorectal Cancer: A Double-Edged Sword by Tumor Location?
    J Natl Cancer Inst. 2021 Sep 1. pii: 6360117. doi: 10.1093.
    PubMed    


    August 2021
  24. ENG C, Hochster H
    Early-Onset Colorectal Cancer: The Mystery Remains.
    J Natl Cancer Inst. 2021 Aug 18. pii: 6353734. doi: 10.1093.
    PubMed    


  25. BREUER E, Hebeisen M, Schneider MA, Roth L, et al
    Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis.
    J Natl Cancer Inst. 2021;113:1027-1035.
    PubMed     Abstract available


    July 2021
  26. UGAI T, Vayrynen JP, Haruki K, Akimoto N, et al
    Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates.
    J Natl Cancer Inst. 2021 Jul 15. pii: 6321960. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  27. TEN HOORN S, de Back TR, Sommeijer DW, Vermeulen L, et al
    Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2021 Jun 2. pii: 6291249. doi: 10.1093.
    PubMed     Abstract available


  28. YIN J, Cohen R, Jin Z, Liu H, et al
    Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
    J Natl Cancer Inst. 2021 Jun 1. pii: 6290718. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  29. RANDON G, Yaeger R, Hechtman JF, Manca P, et al
    EGFR Amplification in Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2021 Apr 7. pii: 6213909. doi: 10.1093.
    PubMed     Abstract available


  30. WAGNER AD, Grothey A, Andre T, Dixon JG, et al
    Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
    J Natl Cancer Inst. 2021;113:400-407.
    PubMed     Abstract available


  31. ZAANAN A, Henriques J, Cohen R, Sefrioui D, et al
    Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin.
    J Natl Cancer Inst. 2021;113:496-500.
    PubMed     Abstract available


    March 2021
  32. WANG K, Ma W, Wu K, Ogino S, et al
    Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Mar 18. pii: 6178004. doi: 10.1093.
    PubMed     Abstract available


  33. DEMB JB, Gupta S
    Realizing the Promise of Personalized Colorectal Cancer Screening in Practice.
    J Natl Cancer Inst. 2021 Mar 18. pii: 6178006. doi: 10.1093.
    PubMed    


  34. COHEN R, Liu H, Fiskum J, Adams R, et al
    BRAF V600E Mutation in First-line Metastatic Colorectal Cancer: an Analysis of Individual Patient Data from the ARCAD Database.
    J Natl Cancer Inst. 2021 Mar 18. pii: 6178005. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  35. MCNEIL JJ
    Aspirin and primary prevention of colorectal cancer: a still evolving story.
    J Natl Cancer Inst. 2021 Feb 2. pii: 6123750. doi: 10.1093.
    PubMed    


  36. ZHANG Y, Chan AT, Meyerhardt JA, Giovannucci EL, et al
    Timing of aspirin use in colorectal cancer chemoprevention: a prospective cohort study.
    J Natl Cancer Inst. 2021 Feb 2. pii: 6123749. doi: 10.1093.
    PubMed     Abstract available


  37. FIGUEIREDO JC, Jacobs EJ, Newton CC, Guinter MA, et al
    Associations of aspirin and non-aspirin non-steroidal anti-inflammatory drugs with colorectal cancer mortality after diagnosis.
    J Natl Cancer Inst. 2021 Feb 2. pii: 6123748. doi: 10.1093.
    PubMed     Abstract available


  38. RANSOHOFF DF
    Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making.
    J Natl Cancer Inst. 2021;113:109-111.
    PubMed    


    January 2021
  39. HOWREN A, Sayre EC, Loree JM, Gill S, et al
    Trends in the incidence of young-onset colorectal cancer with a focus on years approaching screening age: A population-based longitudinal study.
    J Natl Cancer Inst. 2021 Jan 25. pii: 6119347. doi: 10.1093.
    PubMed     Abstract available


  40. FEDEWA SA, Anderson JC, Siegel RL
    Colorectal Cancer incidence in Canada: what do rates at age 50 years reflect?
    J Natl Cancer Inst. 2021 Jan 25. pii: 6119348. doi: 10.1093.
    PubMed    


    December 2020
  41. JOSHI AD, Chan AT
    Racial differences in epigenetic aging of the colon: Implications for colorectal cancer.
    J Natl Cancer Inst. 2020 Dec 30. pii: 6055552. doi: 10.1093.
    PubMed    


    November 2020
  42. SNYDER RA, Hu CY, Zafar SN, Francescatti A, et al
    Racial Disparities in Recurrence and Overall Survival in Patients with Locoregional Colorectal Cancer.
    J Natl Cancer Inst. 2020 Nov 24. pii: 5999805. doi: 10.1093.
    PubMed     Abstract available


  43. MANZ CR, Schrag D
    Racial disparities in colorectal cancer recurrence and mortality: equitable care, inequitable outcomes?
    J Natl Cancer Inst. 2020 Nov 24. pii: 5999804. doi: 10.1093.
    PubMed    


  44. ZHENG X, Hur J, Nguyen LH, Liu J, et al
    Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2020 Nov 2. pii: 5951179. doi: 10.1093.
    PubMed     Abstract available


  45. MURPHY N, Campbell PT, Gunter MJ
    Unravelling the etiology of early-onset colorectal cancer.
    J Natl Cancer Inst. 2020 Nov 2. pii: 5951177. doi: 10.1093.
    PubMed    


    September 2020
  46. ALDERSON PO, Summers RM
    The Evolving Status of Radiomics.
    J Natl Cancer Inst. 2020;112:869-870.
    PubMed    


    August 2020
  47. ROBERTS AW, Eiffert S, Wulff-Burchfield EM, Dusetzina SB, et al
    Opioid use disorder and overdose in older adults with breast, colorectal, or prostate cancer.
    J Natl Cancer Inst. 2020 Aug 17. pii: 5893484. doi: 10.1093.
    PubMed     Abstract available


  48. ROMESSER PB, Smith G, Crane CH
    Nonoperative Management of Rectal Cancer Shows Cost-Effectiveness, but Can Comparative Effectiveness Be Established?
    J Natl Cancer Inst. 2020;112:771-772.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: